Product image of Montelucaste Ratiopharm (Montelukast Sodium) supplied by GNH India

Montelucaste Ratiopharm

Active Ingredient:
Montelukast Sodium
Origin:
EU

Montelucaste Ratiopharm (Montelukast Sodium)

Montelukast, the active ingredient in Montelucaste Ratiopharm, is a leukotriene receptor antagonist presented as a tablet for oral use. It is employed to manage asthma, exercise‑induced bronchoconstriction, and allergic rhinitis in adults and children, while providing symptom relief as part of a long‑term management plan.

GNH India supplies Montelucaste Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. The company maintains a robust distribution network across the EU and other global markets.

Manufacturer / TM Owner

Ratiopharm-Comercio E Industria De Produtos Farmaceuticos Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Montelukast, a leukotriene receptor antagonist, is used in respiratory and allergic disease management.

  • Asthma: Improves control of chronic symptoms and reduces frequency of exacerbations.
  • Exercise‑induced bronchoconstriction: Prevents airway narrowing triggered by physical activity.
  • Allergic rhinitis: Alleviates nasal congestion, sneezing, and itchy eyes associated with seasonal allergies.

How It Works

  • Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1 on airway smooth‑muscle cells, mast cells, and eosinophils. By antagonizing leukotrienes D4, E4 and C4, it inhibits the inflammatory cascade that leads to bronchoconstriction, mucus secretion, and vascular permeability, thereby improving airway patency and reducing allergic inflammation. The inhibition is competitive and reversible, allowing normal leukotriene function to resume when the drug is cleared.

Side Effects

Montelukast is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Upper respiratory tract infection: transient symptoms.
  • Cough: occasional dry cough.
  • Abdominal pain: mild discomfort.
  • Diarrhea: loose stools.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Allergic reactions: hives, swelling, or anaphylaxis.
  • Neuropsychiatric events: agitation, depression, or suicidal thoughts.
  • Hepatotoxicity: elevated liver enzymes.
  • Angioedema: swelling of face, lips, or tongue.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

When prescribing Montelukast, clinicians should consider several precautionary measures to ensure safe use.

  • Indication verification: confirm diagnosis of asthma, exercise‑induced bronchoconstriction, or allergic rhinitis before initiating therapy.
  • Age considerations: use in children according to approved labeling; monitor growth in pediatric patients.
  • Hepatic function: assess liver status in patients with known hepatic impairment.
  • Neuropsychiatric monitoring: observe for mood changes, depression, or suicidal ideation during treatment.
  • Drug interactions: review concomitant medications for potential interactions that may affect efficacy or safety.
  • Store at ambient temperature: keep tablets below 25 °C in the original container, protected from moisture and direct sunlight.

Avoid Interactions

Montelukast may interact with other medicines, altering its effectiveness or increasing the risk of adverse effects.

Major Interactions (Avoid)

  • Ritonavir: strong CYP3A4 inhibition can increase montelukast plasma levels.
  • Ketoconazole: potent CYP3A4 inhibitor may raise drug exposure.

Moderate Interactions (Monitor Closely)

  • Phenobarbital: enzyme inducer that may reduce montelukast concentrations.
  • Carbamazepine: moderate CYP3A4 inducer potentially decreasing efficacy.
  • Warfarin: possible alteration of anticoagulant effect; monitor INR.
  • Oral contraceptives: may slightly increase montelukast levels; observe for side effects.

Frequently Asked Questions

Montelucaste Ratiopharm contains the active ingredient montelukast and is prescribed to treat chronic asthma, prevent exercise‑induced bronchoconstriction, and relieve symptoms of allergic rhinitis such as nasal congestion, sneezing, and itchy eyes.

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1 on airway cells, preventing leukotrienes D4, E4 and C4 from triggering bronchoconstriction, mucus production, and inflammation, which helps keep the airways open and reduces allergic responses.

The appropriate dose of Montelucaste Ratiopharm is determined by the prescribing healthcare professional based on the patient’s age, condition, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The pregnancy category for montelukast is not definitively established. It should only be used during pregnancy or lactation if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Montelucaste Ratiopharm, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast is a leukotriene receptor antagonist, offering an oral alternative to inhaled corticosteroids or bronchodilators. It is particularly useful for patients who need additional control of allergic inflammation or who cannot use inhalers effectively, but it is generally used as an adjunct rather than a sole replacement for inhaled steroids.

Montelucaste Ratiopharm tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

The medication is taken orally as a tablet. It should be swallowed whole with a glass of water, and can be taken with or without food. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious adverse reactions, although rare, include allergic responses such as hives, swelling, or anaphylaxis, neuropsychiatric events like depression or suicidal thoughts, and severe skin conditions such as Stevens‑Johnson syndrome. Any of these symptoms require immediate medical attention.

Montelucaste Ratiopharm is contraindicated in individuals with known hypersensitivity to montelukast or any of the tablet’s excipients. Patients with severe hepatic impairment should use it only under close medical supervision, and it should be avoided in anyone who has experienced a serious allergic reaction to the drug.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Montelukast Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT